Medical Product Packaging, Labeling, and Serialization

The contract encompasses the secondary packaging, labeling, and serialization of Ondansetron Hydrochloride Injection, ensuring full compliance with federal regulations and Department of Defense logistics standards, specifically MIL-STD-129, and stringent traceability protocols. This work is critical for maintaining the integrity, identification, and supply chain visibility of the injectable medication as it moves through military and federal healthcare systems. All processes must adhere to exacting specifications for labeling accuracy, barcode formatting, serialization integrity, and packaging durability to meet DoD requirements for receipt, storage, and distribution. The contract is classified as a subcontract under NAICS code 325991, indicating it involves other pharmaceutical and medicinal product manufacturing activities. It is managed by the Defense Logistics Agency under the Department of Defense and is tied to the procurement vehicle SPE2DX25D9900 with delivery order SPE2DP26F8779. The work must be performed in accordance with federal guidelines to ensure seamless integration into Defense Supply Chain operations, with full traceability from production through final delivery to U.S. military medical facilities. The posting date indicates this solicitation was made in August 2026, positioning it for execution in the subsequent fiscal cycle.